Decoy Therapeutics Inc.

DCOY | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.07

-$0.16 (-13.01%)

At close: Oct 30, 2026, 4:00 PM ET

$1.13

+$0.06 (+5.61%)

Pre-market: Nov 2, 2026, 7:02 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-12.52M	-5.58M	-12.54M	-31.61M	-12.77M	-7.35M
Depreciation & Amortization	7.15K	4.42K	10.05K	6.68K	19.18K	18.06K
Stock-Based Compensation	219.06K	273.73K	524.84K	796.8K	559.04K	319.39K
Other Working Capital	120.73K	438.15K	-193.35K	1.06M	99.66K	820.77K
Other Non-Cash Items	8.51M	n/a	130K	10.84M	-44.69K	-258.55K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.05M	772.29K	-968.33K	2.37M	2.03M	-3.04M
Operating Cash Flow	-4.83M	-4.53M	-12.85M	-17.6M	-10.2M	-10.31M
Capital Expenditures	n/a	n/a	-3	-1.5M	n/a	-2.6K
Cash Acquisitions	1.34M	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-577K	n/a	3	-1.5M	n/a	n/a
Investing Cash Flow	764.74K	n/a	n/a	-1.5M	n/a	-2.6K
Debt Repayment	-221.87K	-466.51K	-280.92K	n/a	-477.03K	-974.44K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	1.49M	3.87M
Financial Cash Flow	12.34M	1.06M	6.64M	1.99M	28.3M	17.69M
Net Cash Flow	8.28M	-3.47M	-6.21M	-17.11M	18.1M	7.38M
Free Cash Flow	-4.83M	-4.53M	-12.85M	-19.1M	-10.2M	-10.31M
Adj. Free Cash Flow	-5.05M	-4.8M	-13.37M	-19.89M	-10.76M	-10.63M
Maintenance CapEx	n/a	n/a	-3	-1.5M	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	-2.6K
Owner Earnings	-4.83M	-4.53M	-12.85M	-19.1M	-10.2M	-10.31M